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Mononuclear cell activation and decreased renal function In IgA
nephropathy with crescents. Our previous immunohistologic studies
with monoclonal antibodies (mAb) showed that glomerular and inter-
stitiai accumulations of mononuclear cells (MNC) were common fea-
tures of many types of proliferative glomerulonephritis, especially
crescentic glomerulonephritis. The current study examined a series of
patients with crescentic IgA disease, since IgA disease in general has a
highly variable course and the presence of crescents is one indicator of
likely progression to end-stage renal failure. We compared the intraglo-
merular and interstitial infiltrates within biopsies from patients with
crescentic IgA nephropathy (N = 5) versus those with noncrescentic
IgA (N = 18), or normal controls (N = 10). Few leucocytes were found
within glomeruli of normal (2.4 0.7 cells/glomerular cross section)
(mean SEM) or noncrescentic IgA disease biopsies (3.8 0.7), and no
activated MNC bearing receptors for interleukin-2 (IL-2R) were de-
tected. By contrast, in crescentic IgA disease, glomerular leucocytes
were increased (5.1 0.6, P <0.01), due to increased monocyte (3.1
0.9, P < 0.01) and T cell (1.4 0.4, P < 0.01) infiltration, and IL-2R+
MNC were then observed (1.2 0.5, P < 0.05). Studies of interstitial
cells showed small numbers of leucocytes within normal kidneys (101
16/mm2). Biopsies from noncrescentic IgA disease showed a fivefold
increase in interstitial MNC infiltration (total leucocytes 565 105/
mm2, P <0.01), due to an influx ofT cells (283 59/mm2, P <0.01) and
monocytes (120 32/mm2, P < 0.01), and including a mean of 20%
IL-2R+ MNC (114 29/mm2, P < 0.01). This picture of dramatically
increased interstitial MNC infiltration in IgA disease was further
amplified in IgA disease with crescent formation, when total leucocytes
reached 784 153/mm2 (P < 0.01 vs. normals), due to large numbers of
monocytes (376 83/rn2, P < 0.01 vs. normals or noncrescentic cases)
and T cells (423 99, P < 0.01 vs. normals). In addition, crescentic
biopsies contained even more IL-2R+ cells (44%) than noncrescentic
IgA biopsies (348 96/mm2, P < 0.05 vs. noncrescentic IgA). The
numbers of interstitial total leucocytes (P < 0.05), monocytes (P <
0.05), T cells (P < 0.01) and IL-2R+ (P < 0.01) cells were all positively
correlated with raised serum creatinine, and were negatively correlated
with creatinine clearance. Since IL-2 plays a central role in T cell
activation, and MNC expression of IL-2R is a closely regulated event,
these studies suggest that local cellular immune activation is involved in
the immunopathogenesis of IgA nephropathy, particularly in cases
featuring crescent formation.
IgA nephropathy, responsible for 15 to 40% of cases of
glomerulonephritis worldwide [1], is characterized by a pre-
dominance of mesangial IgA deposition, often in conjunction
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with C3 and IgG and/or 1gM, in the absence of systemic disease
[2]. However, in spite of its high frequency, the etiology and
pathogenesis of IgA disease remain enigmatic. Systemic over-
production of IgA and formation and subsequent renal deposi-
tion of immune complexes are well documented, but the basis
for overproduction and the antigen(s) involved are unidentified
[3]. In addition to disordered humoral immunity, cellular im-
mune defects may also be present, since defective T cell control
of IgA production is reported in patients with IgA disease [4];
however, any contribution of host mononuclear cells to ongoing
glomerular injury once immune complexes have lodged in the
glomerulus is unknown. Clinically, IgA disease has a highly
variable course, with a subgroup of patients progressing to
end-stage renal failure. This progression occurs particularly in
patients who display glomerular crescents, renal impairment,
hypertension or heavy proteinuria at the time of diagnosis [5],
though the relationship of these features to pathogenesis is
uncertain.
We have long had an interest in studying the involvement of
mononuclear cells (MNC) in mediation of glomerular injury [6].
Previously, we reported the results of an immunohistologic
survey of renal biopsies from 145 patients with glomerulone-
phritis, including 18 patients with IgA nephropathy classified
histologically as focal glomerulonephritis without crescent for-
mation [7]. That study showed that though MNC infiltration of
the glomerulus was a common feature of many forms of
proliferative glomerulonephritis, this did not occur in IgA
disease. Other groups studying biopsies from patients with
largely noncrescentic IgA disease have also reported a lack of
glomerular MNC [8—13], suggesting that IgA nephropathy is
thereby different from other forms of human and experimental
immune complex-mediated proliferative glomerulonephntis.
The current study reinvestigated the issue of MNC involve-
ment in IgA disease by comparing the glomerular and interstitial
infiltrates present within biopsies of patients with IgA disease
with or without associated crescent formation. This was done
for several reasons. Firstly, we were aware of the aforemen-
tioned poor prognostic significance of crescent formation com-
pared to patients with noncrescentic IgA disease. Secondly, our
previous clinical [14, 15] and experimental findings [16] with
glomerular infiltration and damage by MNC, particularly mono-
cytes, led us to hypothesize that MNCs may be involved locally
in the immunopathogenesis of crescentic IgA disease. Lastly,
the availability of monoclonal antibodies (mAb) to markers of
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Table 1. Intraglomerular mononuclear cells in IgA disease (N 33)
Total CD4+ CDS+ IL-2R+ CD4:CD8
N leucocytes Monocytes T cells cells cells MNC ratio
Normal controls 10 2.4 0.7' 1.4 0.4 0.3°
(0.1—0.4)
0.1
(0.1—0.2)
0.1
(0.1—0.2)
0.0 1.4 0.4
Non-crescentic IgA 18 3.8 0.7° 0.7 0.3° 0.7°
(0—2.3)
0.6
(0—1.3)
0.7
(0—1.6)
0.9°
(0—2.0)
0.9 0.4
Crescentic IgA 5 5.1 0.6k 3.1 0.9a 1.4 0.4° 0.7°
(0.4—1.0)
0.6
(0—1.0)
1.2 05b 1.2 0.1
a P < 0.01, between normal and IgA nephropathy
' P < 0.05, between normal and IgA nephropathy
P < 0.01, between crescentic and non-crescentic IgA nephropathy' Expressed as cells/glomerular cross section (mean 5EM)
Ranges are shown when numbers were very small
cellular immune activation, such as expression of receptors for
interleukin 2 (IL-2R), provided a new approach to understand-
ing the significance of any MNC infiltration observed.
Based on the use of these markers, the current study suggests
that activated IL-2R+ T cells and monocytes are involved in
the pathogenesis of crescentic IgA disease. Moreover, our
finding that the presence of these activated cells within inter-
stitial areas correlates closely with decreased renal function,
provides new evidence for the concept [12, 13] that local
cellular immune dysfunction contributes to the progression of
IgA disease.
Methods
Tissue
Renal biopsies from 18 patients with non-crescentic and five
patients with crescentic IgA nephropathy were studied. The
non-crescentic biopsies were from eleven males and seven
females, ranging in age from 13 to 81 years, and five crescentic
biopsies were from males aged 20 to 51 years. Crescentic
biopsies typically showed small, focal crescents affecting 10 to
30% of the glomeruli. Normal control tissues consisted of
portions of cadaver nephrectomies which were not used for
transplantation (N = 7), as well as kidneys removed because of
localized tumors (N = 3). All biopsies were assessed by light
microscopy, immunofluorescence and electron microscopy, as
well as immunoperoxidase labelling using anti-leucocyte mAbs.
Portions of each biopsy to be used for immunoperoxidase
studies were fixed in PLP, washed in PBS containing 7%
sucrose, snap frozen and stored at —80°C until cryostat section-
ing, as described previously [17].
Immunoperoxidase labelling with mAbs
Details of the panel of anti-leucocyte mAbs directed against
various lineage-specific or MNC activation antigens were pre-
sented previously [7, 181. Antibodies and their specificities are:
PHM1 (CD45), all leucocytes, but not renal interstitial dendritic
cells; FMC32 (CD14), mononuclear phagocytes and renal inter-
stitial dendritic cells; OKT3 (CD3), all T cells; OKT1 I (CD2),
all T cells; OKT4 (CD4), helper/inducer T cell subset; OKT8
(CD8), cytotoxic/suppressor T cell subset; Tac-1 (CD25), IL-2R
present on activated MNC (including T cells, B cells, mono-
cytes and NK cells). B cells were detected by the presence of
surface immunoglobulin or labelling with B 1 mAb. Immunoper-
oxidase labelling was performed using a four-layer PAP tech-
nique with DAB as the chromogen [17]. Sections were then
counterstained with hematoxylin and mounted.
Assessment of glomerular injury, MNC quantitation and
statistics
The extent of glomerular injury was graded into predomi-
nantly mild, moderate or severe, by an experienced renal
pathologist (J.P.D.) as part of the diagnostic evaluation at the
time of renal biopsy. This grading used standard criteria [3]:
marginal focal and segmental mesangial proliferation with
patent capillaries and normal vessel walls (mild); prominent
mesangial proliferation, resulting in "arborization" of the tuft,
in some cases with early double contouring and narrowing of
capillary loops (moderate); and extensive mesangial expansion
with tuft collapse, hyalinosis and/or sclerosis (severe).
Quantitative analysis of infiltrating MNC was performed
independently and without knowledge of clinical or histopatho-
logic data. For each biopsy, the number of labelled cells within
each glomerulus was counted and expressed as mean cells
5EM/glomerular cross section. Cells within crescents were in-
cluded in glomerular counts because almost all crescents were
small and closely associated with glomerular tufts, rendering
difficult discrimination between leucocytes within tufts and
those within associated but infrequent crescents. The number
of glomeruli contained within each biopsy ranged from 4 to 15.
Labelled interstitial MNC were counted with the aid of an
ocular grid (0.02 mm2). Twenty adjacent fields, totalling 0.4
mm2, were counted, and results of interstitial MNC counts were
standardized and expressed as mean cells sEM/mm2. Cell
counts were performed three times to reduce counting errors,
and if different results were obtained then all positive cells
within the section were enumerated. Absolute numbers of
labelled cells in different groups were compared using a two-
tailed Wilcoxon rank sum test, and correlations were deter-
mined using Spearman's test.
Renal function
Renal function was assessed by measurement of serum
creatinine, 24-hour creatinine clearance and determination of
the glomerular filtration rate at the time of biopsy. The results of
renal function and urinary parameters were incomplete for
many of the normal control kidneys because of the circum-
stances associated with procurement. Hence, comparisons of
creatinine clearance and urinary indices between normals and
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Table 2. Interstitial MNC cells in IgA disease (N = 23) or normal renal biopsies (N = 10)
Total IL-2R+
N leucocytes Monocytes T cells CD4+ cells CD8+ cells MNC
CD4:CD8
ratio
Normal 10 101 37 (37%) 29 (29%) 15 (15%) 13 (13%) 0.0 (0%)
Non-cresc. 18 565 120 (21%) 283 (50%) 151 (27%) 137 (24%) 114 (20%) 1.4
IgA 598
Crescentic 5 784 376 (48%) 423 (54%) 225 (29%) 184 (24%) 348 (44%) 1.3
83a,b 99a
a P < 0.01, between normal and IgA nephropathy
b p < 0.01, between crescentic and non-crescentic IgA nephropathy
P < 0.05, between crescentic and non-crescentic IgA nephropathy
d Expressed as cells/mm2 (mean SEM)
Table 3. Correlation between interstitial mononuclear cells and renal function in IgA nephropathy with crescents (N 5)
Total IL-2R+ CD4+ CD8+ CD4:CD8
leucocytes Monocytes T cells cells cells cells ratio
Serum creatinine r = 0.91 r = 0.89 r = 0.99 r = 0.98 r 0.98 NS NS
P < 0.05 P < 0.05 P < 0.01 P < 0.01 P < 0.01
Creatinine clearance r = —0.99 r = —0.93 r = —0.91 r = —0.92 NS NS NS
P < 0.01 P < 0.05 P < 0.05 P < 0.05
Urinary protein excretion NS NS NS NS NS NS NS
Urinary red cell excretion NS NS NS NS NS NS NS
NS, not significant (F> 0.05)
IgA cases were often not possible, though comparative data for
noncrescentic and crescentic IgA disease were available.
Results
Intraglomerular mononuclear cells
Few intraglomerular leucocytes were encountered in normal
renal tissue (2.4 0.7 cells/glomerular cross section); these
consisted of monocytes (1.4 0.4) and lesser numbers of T
cells (0.3, range 0.1 to 0.4, Table 1). No IL-2R+ cells were
detected. Similarly, there was no statistically significant differ-
ence in the numbers of any leucocyte population within glomer-
uli from patients with noncrescentic IgA disease except for
small numbers of IL-2R+ cells (1.2 0.5, P < 0.01).
By contrast, glomeruli from patients with crescentic IgA
disease (Table 1) showed significantly increased numbers of
total leucocytes (5.1 0.6, P < 0.01), due to increases in
monocytes (3.1 0.9, P < 0.01) and T cells (1.4 0.4, P <
0.01) of both CD4+ and CD8+ phenotypes. The number of
IL-2R+ MNC was also increased (1.2 0.5, P < 0.05)
compared to normal but not noncrescentic glomeruli. These
increases in the numbers of intraglomerular monocytes and T
cells in crescentic IgA disease did not vary in response to the
presence or distribution of immune reactants, as assessed by
ultrastructural evaluation for the presence of electron-dense
deposits, and immunofluorescent localization of IgG, 1gM, C3
or fibrinogen/fibrin (data not shown). Nor did the presence of
glomerular leucocytes, whether monocytes, T cells or IL-2R+
MNC correlate with alterations in serum creatinine, creatinine
clearance, urinary protein excretion or urinary RBC excretion
in the five patients with crescentic IgA disease (data not
shown).
Interstitial mononuclear cells
Interstitial areas of normal human kidneys contained small
numbers of leucocytes (101 16 cells/mm2), consisting of
generally equal proportions of monocytes and T cells; no
IL-2R+ cells were detected (Table 2). Development of noncres-
centic IgA disease was associated with a fivefold increase in
cellularity (total leucocytes 565 105/mm2, P < 0.01), due to
increased numbers of T cells and monocytes (both P < 0.01 vs.
normal). The CD4:CD8 ratio remained unchanged (1.4 0.2),
whereas there was a significant increase in the numbers of
IL-2R+ interstitial MNC (114 29, P < 0,01). By comparison
with normal kidneys, crescentic IgA disease was associated
with a sevenfold increase in interstitial MNC (total leucocytes
784 153/mm2, P <0.01) consisting, like noncrescentic cases,
of large numbers of monocytes and T cells. However, crescen-
tic cases showed even more monocytes (376 83 vs. 120 32,
P < 0.01) and IL-2R+ MNC (348 96 vs. 114 29, P <0.05)
than noncrescentic biopsies.
Interstitial MNC infiltration was strongly associated with
decreased creatinine clearance (r = —0.99, Table 3), in contrast
to the lack of statistically significant correlations between the
presence of intraglomerular leucocytes and various renal indi-
ces. Thus, the numbers of total leucocytes, monocytes, T cells
and IL-2R+ MNC were each correlated with decreased creat-
mine clearance and increased serum creatinine, but did not
correlate with urinary protein or RBC excretion. In addition,
blinded histologic assessment showed increases in the numbers
of total interstitial leucocytes (P < 0.01) and T cells (P < 0.01),
though not monocytes (P > 0.05), were associated with severe
glomerular injury (Table 4).
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Table 4. Comparison of interstitial mononuclear ccils and degree of glomerular injury in IgA disease (N = 23)
N
Total
leucocytes P Monocytes P T cells P
Mild
Moderate
Severe
10
7
6
295.6 72.4e
769.3 154.8
984.0 161.9
>005b
>0.05
<0.0l'
85.0 22.4
275.0 80.4
263.0 98.5
>0.05"
>0.05c
>0.05"
117.9 19.9
402.5 94.1
467.2 112.7
>005b
>0.05c
<001"
a Based on histologic assessment of glomerular injury
"Between groups Mild and Moderate
Between groups Moderate and Severed Between groups Mild and Severe
Expressed as cells mm2 (mean 5EM)
Discussion
This study investigated the contribution of leucocyte infiltra-
tion to the glomerular and interstitial hypercellularity and
decreased renal function which are characteristic of the sub-
group of cases of IgA nephropathy involving crescent formation
at the time of initial biopsy [3, 5]. This subgroup was chosen for
study since, for unknown reasons, crescent formation at the
time of initial biopsy is associated with more than a fivefold
increase in progression to end-stage renal failure, compared to
non-crescentic IgA nephropathy [5]. In addition, it is becoming
increasingly clear from studies using glomerular cultures [141 or
mAbs [7, 10, 15] that regardless of etiology, essentially all forms
of crescentic glomerulonephritis examined to date appear to
involve glomerular infiltration and injury by monocytes.
Focusing initially on the glomerular changes, we found that
compared with glomeruli within normal tissues or biopsies
showing IgA disease without crescents, glomeruli in crescentic
IgA disease contained significantly increased numbers of total
leucocytes, particularly monocytes and T cells (Table 1). More-
over, using a mAb to the p55 (beta) chain of the IL-2R, 24% of
the intraglomerular leucocytes were IL-2R+. The identity of
these IL-2R+ cells is as yet unknown, but given the intraglo-
merular predominance of monocytes plus T cells, IL-2R+ T
cells and/or IL-2R+ monocytes are likely. IL-2/IL-2R interac-
tions are well known to play a critical role in T cell activation
and clonal expansion [19]. By contrast, data concerning the
biologic significance of monocyte IL-2R expression [20] is
scanty, though it is known that just as for T cells, receptor
expression appears to be closely regulated [21], and IL-2
binding to the monocyte IL-2R greatly amplifies IL-I produc-
tion [221. Indeed, we recently demonstrated that isolated gb-
mcmli from patients with crescentic GN produced IL-i in vitro,
and postulated this was in part due to synthesis by infiltrating
monocytes [23]. In the current study, no evidence of intraglo-
merular B cells was found, consistent with the notion that the
IL-2R+ MNC observed reflected T cell/monocyte immune
activation rather than IL-2R+ B cells.
Since IgA nephropathy is thought to be an immune complex-
mediated glomerulonephritis, the presence of intraglomerular
MNC could be postulated as a chemotactic response by mono-
cytes to complement fragments such as C3a and C5a. However,
the requisite IgA antibodies are not potent activators of com-
plement, especially not the classical pathway, nor was there
any correlation between the presence of immune complexes
and detection of intraglomerular monocytes or other MNC.
Hence accumulation of monocytes cells appears independent of
immune complex deposition, and is more characteristic of a
delayed-type hypersensitivity (DTH) response given the co-
involvement of T cells, primarily CD4+, and immune activation
as indicated by MNC expression of IL-2R. Such a response
could be initiated by wandering T cells in response to antigen
trapped within immune complexes, following their phagocyto-
sis, processing and presentation on the surface of Class 11+
resident mononuclear phagocytes. Alternately, this could indi-
cate a DTH response to some of the various matrix-associated
neoantigens expressed during the progressive sclerosis of
chronic IgA disease [11].
Interstitial leucocytes were increased in noncrescentic IgA
nephropathy compared to normal tissues, as previously re-
ported [7, 12, 13]. This influx was further amplified in crescentic
IgA disease, whereby large numbers of T cells and monocytes
were detected throughout the interstitium and in periglomerular
collections (Table 2). Some 44% of these leucocytes were
IL-2R+, indicating potent immune activation, and importantly,
presence of these interstitial MNC correlated closely with
decreased renal function (Table 3). By contrast, there was no
statistically significant correlation observed between the influx
of leucocytes into the gbomerulus and renal function. The lack
of such correlation with glomerular leucocytes is puzzling if
these cells are thought to be of pathogenetic significance, but
the timing of the biopsy and the rapid and aggressive course of
this lesion are confounding variables. Alternately, the statisti-
cally significant association between glomerular injury and the
presence of interstitial MNC (Table 4) may reflect local cyto-
kine production by activated cells with damage to adjacent
structures, including the glomerulus, as can be seen in B
cell-deficient experimental animals following transfer of GBM
antigen-sensitized T cells [24]. Consistent with this hypothesis,
increased levels of activated T cells expressing IL-2R and Class
II antigens, and spontaneously producing and releasing IL-2,
have been detected in the circulation of patients with IgA
nephropathy [25].
Previous studies of IgA nephropathy have commented on
interstitial MNC infiltrates. Thus, one study of 51 patients with
noncrescentic IgA nephropathy drew attention to the impor-
tance of tubulo-interstitial lesions, including tubular atrophy,
interstitial infiltration and fibrosis [26]. Declining renal function
over 8 to 15 years correlated with the presence of tubulo-
interstitial deposits of Ig and complement (P < 0.001) and with
the presence of interstitial MNC (P < 0.05), but not with
glomerular MNC infiltrates. In addition, two other groups
studying IgA disease have recently reported a correlation
between increased numbers of interstitial T cells and tububo-
interstitial damage [12, 13]. The current study extends these
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results through demonstration that almost half of these cells
appear to be immunologically activated and hence functionally
competent, rather than non-specifically trapped andlor inert
bystander cells.
In summary, this study shows the subgroup of cases of IgA
disease with crescents is distinguished from those without
crescents by glomerular and interstitial infiltration by activated
T cells and monocytes. Such interstitial infiltration is correlated
with decreased renal function, suggesting participation of cell-
mediated immunity in the evolution of IgA disease with cres-
cents.
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